Editorial content

Our November 2017 issue is live

Our November issue covers CNS disorders, gene therapy and pharmaceutical deal preparation.

Go to the profile of Raveena Bhambra
Nov 01, 2017
3
0
Upvote 3 Comment

Read our November 2017 edition here.

Our last issue of the year includes a host of company profiles actively seeking partners and three features that cover dealmaking trends within CNS disorders, a timeline of gene therapy events and information regarding how to prepare for a pharmaceutical deal. 

November features 

  • Partnering for CNS disorders 
  • Taking a journey through gene therapy
  • How to prepare for a pharmaceutical deal
Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.